Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

How Much Does Each Advisor “Insight” Actually Cost?

Even before the concept of physical/social distancing was born, Impetus Digital was a strong advocate for virtual collaboration. In our latest video, we explore another key benefit of asynchronous online...

Impetus Digital

- PMLiVE

It’s not just our logo that’s green

Origins Insights believe not only in the value of understanding how people interact with their health, but also the need to care for the wider world around us.

Bedrock Healthcare Communications

- PMLiVE

Current and future trends for developing digital medical communications

Evolving digital trends and user needs

- PMLiVE

Today’s reality: how to make social distancing work in medcomms

At Lucid, we don’t just want to cope with COVID-19.The current situation certainly presents an unprecedented challenge to delivering medical education. The daily update of cancellations and postponements has become...

Lucid Group Communications Limited

- PMLiVE

Q&A: Kate Paxton

PME interview's JPA Health's senior VP

- PMLiVE

Mobile ethnography means no delays to the PoTS LIVE charity project

The team at Origins Insights are excited to introduce PoTS LIVE, our pro bono mobile ethnography project. Remarkably, the project marches on with its fieldwork phase even with the current...

Bedrock Healthcare Communications

- PMLiVE

Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs

The five-year deal includes Sitryx’ two lead projects

Delivering true value: what does it mean for KAM in cancer care?

Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve

Wilmington Healthcare

- PMLiVE

Remote Working: Join the Revolution Workshop

As a nation, we are still coming to terms with our ‘new normal’, where social distancing has forced us out of the office and into our homes. For some this...

Lucid Group Communications Limited

- PMLiVE

Pharma funding and M&A in 2020

Why pharma M&A has continually bucked the trend

AstraZeneca AZ

AZ’s Imfinzi gets US OK in small cell lung cancer, challenging Tecentriq

First checkpoint inhibitor to challenge Roche's Tecentriq in this indication

- PMLiVE

Amarin shares tumble following Vascepa patent loss

Judgement invalidates six key patents on fish-oil derived med

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links